Tingsheng Lin

1.3k citations
26 papers · 1.0k indexed · 1 hit paper · h-index 18
Topics
Bladder and Urothelial Cancer Treatments (7 papers)Nanoplatforms for cancer theranostics (7 papers)Renal cell carcinoma treatment (3 papers)
Partner nations
ChinaCzechiaIreland

In The Last Decade

Tingsheng Lin

25 papers receiving 1.0k citations

Hit Papers

O2-generating MnO2 nanoparticles for enhanced photodynami...2018202620202023201850100150200250

Peers

Tingsheng Lin
Comparison fields: 5 of 92
  • Biomedical Engineering 454
  • Materials Chemistry 292
  • Molecular Biology 281
  • Pulmonary and Respiratory Medicine 212
  • Surgery 188
Replace Yuchan You with:
Yuchan You China
Anna Guller Australia
Dexuan Xiao China
Weitong Cui China
Shaohui Huang China
Zhuang Tang China
Chong Ma China
Yuan Yu China
Wenhao Wang China
Tingsheng Lin relative to Yuchan You China Yuchan You's profile →
Citations per field
00.5×10×20×29.7×
Yuchan You · 1×
Citations per year

Countries citing papers authored by Tingsheng Lin

Since Specialization
Citations

This map shows the geographic impact of Tingsheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingsheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingsheng Lin more than expected).

Fields of papers citing papers by Tingsheng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingsheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingsheng Lin. The network helps show where Tingsheng Lin may publish in the future.

Co-authorship network of co-authors of Tingsheng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Tingsheng Lin. A scholar is included among the top collaborators of Tingsheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingsheng Lin. Tingsheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 27
3 39
4 8
5 29
6 2
7 39
8 7
9 104
10 78
11 36
12 103
13 53
14 25
15 17
16 30
17 6
18 28
19 49
20 24

About Tingsheng Lin

Tingsheng Lin is a scholar working on Urology, Pharmaceutical Science and Rheumatology, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Biomaterials (174 citations), Urology (69 citations) and Biomedical Engineering (454 citations). Tingsheng Lin has collaborated with scholars based in China, Czechia and Ireland. Frequent co-authors include Hongqian Guo, Xiaozhi Zhao, Wenmin Cao, Hui Wei, Sheng Zhao, Wei Chen, Hang Yu, Huibo Lian, Jinhui Wu and Yiqiao Hu. Their work appears in journals such as Nature Communications, Biomaterials and Acta Biomaterialia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026